Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Bartlett, Susan J ^a,b   Orbai, Ana Maria ^b   Duncan, Trisha ^b   DeLeon, Elaine ^b   Ruffing, Victoria ^b   Clegg Smith, Katherine ^c   Bingham, Clifton O ^b  

^a MCGILL UNIVERSITY   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ANGER; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CONVERGENT VALIDITY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DISEASE ACTIVITY; DISEASE ASSESSMENT; FATIGUE; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MOOD; OBSERVATIONAL STUDY; PAIN; PATIENT REPORTED OUTCOME MEASUREMENT INFORMATION SYSTEM; PHYSICAL CAPACITY; PROMIS; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SLEEP; SYMPTOM; TEST RETEST RELIABILITY; ARTHRITIS, RHEUMATOID; DISABILITY; MIDDLE AGED; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ANGER; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SLEEP; SURVEYS AND QUESTIONNAIRES;

EID: 84945529690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138543     Document Type: Article

References (42)

1. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012; 307(15):1583-4. doi: 307/15/1583 [pii]; doi: 10.1001/jama.2012.500 PMID: 22511682
2. Santana MJ, Haverman L, Absolom K, Takeuchi E, Feeny D, Grootenhuis M, et al. Training clinicians in how to use patient-reported outcome measures in routine clinical practice. Qual Life Res. 2015. doi: 10.1007/s11136-014-0903-5 PMID: 25589231.
3. Food and Drug Administration. Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims. Federal Register. 2009; 74(235):65132-3.
4. Centers for Disease Control and Prevention. Prevalence and most common causes of disability among adults-United States, 2005. MMWR Morbidity and mortality weekly report. 2009; 58(16):421-6. PMID: 19407734.
5. Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis and rheumatism. 2006; 54(1):226-9. doi: 10.1002/art.21562 PMID: 16385518.
6. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and rheumatism. 2008; 58(1):26-35. doi: 10.1002/art.23176 PMID: 18163497; PubMed Central PMCID: PMC3266664.
7. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and rheumatism. 2008; 58(1):15-25. doi: 10.1002/art.23177 PMID: 18163481.
8. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care Res (Hoboken). 2010; 62(5):640-6. Epub 2010/05/13. doi: 10.1002/acr.20034 PMID: 20461785; PubMed Central PMCID: PMC2887082.
9. Sanderson T, Kirwan J. Patient-reported outcomes for arthritis: time to focus on personal life impact measures? Arthritis and rheumatism. 2009; 61(1):1-3. Epub 2009/01/01. doi: 10.1002/art.24270 PMID: 19116964.
10. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993; 36(6):729-40. PMID: 8507213
11. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis. Arthritis Care & Research. 2012; 64(5):625-39. doi: 10.1002/acr.21641
12. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. Journal of Rheumatology. 2007; 34(5):1174-7. PMID: 17477482
13. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis & Rheumatism. 2005; 53(5):697-702.
14. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. What outcomes from pharmacologic treatments are important to people with rheumatoid arthritis? Creating the basis of a patient core set. Arthritis Care & Research. 2010; 62(5):640-6.
15. Bartlett SJ, Hewlett S, Bingham CO 3rd, Woodworth TG, Alten R, Pohl C, et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis. 2012; 71(11):1855-60. doi: 10.1136/annrheumdis-2011-201201 PMID: 22772326.
16. Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009; 68(11):1680-5. doi: 10.1136/ard.2008.100271 PMID: 19054825.
17. Berthelot JM, De BM, Morel J, Benatig F, Constantin A, Gaudin P, et al. A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: The 'FLARE' instrument. Ann Rheum Dis. 2012; 71(7):1110-6. doi: ard.2011.150656 [pii]; doi: 10.1136/ard.2011.150656 PMID: 22072015
18. Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, et al. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol. 2011; 38(8):1751-8. doi: 10.3899/jrheum.110401 PMID: 21807797.
19. Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett SE, et al. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. J Rheumatol. 2011; 38(8):1745-50. doi: 10.3899/jrheum.110400 PMID: 21807796.
20. Bingham CO III, Alten R, de Wit MP. The importance of patient participation in measuring rheumatoid arthritis flares. Ann Rheum Dis. 2012; 71(7):1107-9. doi: annrheumdis-2011-200870 [pii]; doi: 10.1136/annrheumdis-2011-200870 PMID: 22323439
21. Methodology Committee of the Patient-Centered Outcomes Research I. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA. 2012; 307 (15):1636-40. doi: 10.1001/jama.2012.466 PMID: 22511692.
22. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health. 2011; 14(8):978-88. doi: 10.1016/j.jval.2011.06.013 PMID: 22152166.
23. PROMIS instrument development and psychometric evaluation scientific standards 2014.
24. Fries JF, Cella D, Rose M, Krishnan E, Bruce B. Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. Journal of Rheumatology. 2009; 36(9):2061-6. doi: 10.3899/jrheum.090358 PMID: 19738214
25. Fries JF, Krishnan E, Rose M, Lingala B, Bruce B. Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory. Arthritis Research & Therapy. 2011; 13(5):R147. doi: ar3461 [pii]; doi: 10.1186/ar3461
26. Fries JF, Bruce B, Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin ExpRheumatol. 2005; 23(5 Suppl 39):S53-S7.
27. Bykerk VP, Bingham CO III, Choy EH, Boire G, Haraoui B, Lin D, et al. The OMERACT Preliminary Flare Questionnaire (PFQ) is responsive to change and able to cetect clinically important worsening indicating need for treatment change in the Canadian early arthritis cohort. EULAR 20142014.
28. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010; 63(11):1179-94. doi: 10.1016/j. jclinepi.2010.04.011 PMID: 20685078
29. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care. 2007; 45(5 Suppl 1):S3-S11. PMID: 17443116
30. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis. 2008; 67(10):1360-4. doi: 10.1136/ard.2008.091454 PMID: 18791055
31. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases. 2010; 69(9):1580-8. doi: 10.1136/ard.2010.138461 PMID: 20699241
32. Hewlett S, Sanderson T, May J, Alten R, Bingham CO 3rd, Cross M, et al. 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count-an international patient perspective on flare where medical help is sought. Rheumatology (Oxford). 2012; 51(1):69-76. doi: 10.1093/rheumatology/keq455 PMID: 21565901.
33. Schipper LG, van Hulst LT, Grol R, van Riel PL, Hulscher ME, Fransen J. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology (Oxford). 2010; 49(11):2154-64. doi: keq195 [pii]; doi: 10.1093/rheumatology/keq195
34. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014; 73(3):492-509. doi: 10.1136/annrheumdis- 2013-204573 PMID: 24161836; PubMed Central PMCID: PMC3933074.
35. Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res. 2006; 15(9):1533-50. doi: 10.1007/s11136-006-0025-9 PMID: 17031503.
36. Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999; 48(11):1507-15. PMID: 10400253.
37. Orbai AM, Smith KC, Bartlett SJ, De Leon E, Bingham CO 3rd. "Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014; 66(11):1662-72. doi: 10.1002/acr.22374 PMID: 24891304; PubMed Central PMCID: PMC4211985.
38. Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, et al. The case for an international patient-reported outcomes measurement information system (PROMIS(R)) initiative. Health Qual Life Outcomes. 2013; 11:210. doi: 10.1186/1477-7525-11-210 PMID: 24359143; PubMed Central PMCID: PMC3879205.
39. Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011; 18(3):263-83. Epub 2011/06/24. doi: 10.1177/1073191111411667 PMID: 21697139; PubMed Central PMCID: PMCPMC3153635.
40. Schalet BD, Cook KF, Choi SW, Cella D. Establishing a common metric for self-reported anxiety: linking the MASQ, PANAS, and GAD-7 to PROMIS Anxiety. J Anxiety Disord. 2014; 28(1):88-96. doi: S0887-6185(13)00215-6 [pii]; doi: 10.1016/j.janxdis.2013.11.006
41. Choi SW, Schalet BD, Cook KF, Cella D. Establishing a Common Metric for Depressive Symptoms: Linking the BDI-II, CES-D, and PHQ-9 to PROMIS Depression. Psychol Assess. 2014.
42. Lai JS, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011; 92(10 Suppl):S20-S7. doi: S0003-9993(11)00680-0 [pii]; doi: 10.1016/j.apmr.2010.08.033